RAF1 and melanoma: Furthermore, by decreasing the expression levels of EGFR, IGF-1R and CRAF, miR-7 could inhibit the activation of RAS/RAF/MEK/ERK (MAPK) and PI3K/AKT pathway and partially reverse the resistance to BRAFi in VemR A375 melanoma cells.